Bio-Techne Corp. vs Abbvie Inc.
TECH vs ABBV — side-by-side comparison from reported financials. TECH leads 6, ABBV leads 6 of 12 comparable metrics.
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | TECH | ABBV |
|---|---|---|
| Price | $72.44 | $276.43 |
| Market cap | $11.4B | $488B |
| Revenue (TTM) | $1.22B | $64.4B |
| Revenue growth | +2.3% | +1.8% |
| Net margin | 15.0% | 9.8% |
| Free cash flow | $263M | $18.2B |
| Net cash (debt) | ($23.6M) | ($56.2B) |
| 1-year price return | +20.9% | +19.8% |
| P/E | 62.5 | 77.4 |
| P/E vs own history (cheap-side %) | 14% | 23% |
| Dividend yield | 0.44% | 2.45% |
| Return on equity | 9% | 96% |
| Altman Z-score | 15.94 | 2.33 |
| CV checks passed | 8 of 11 | 9 of 11 |
| Employees | 3,000 | 57,000 |
Full résumé-style profiles: TECH CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.